OAR 325-015-0045
Patient Notification of “Serious Adverse Events”


After a Serious Adverse Event occurs, a Pharmacy Participant must provide written notification to each affected patient, or, if necessary, to the patient’s personal representative. Notification must be timely and should be consistent with the Pharmacy Participant’s internal communication and disclosure policies.


As provided in ORS 442.837 (Oregon Patient Safety Reporting Program)(4), notice provided under this subsection may not be construed as an admission of liability in a civil action.

Source: Rule 325-015-0045 — Patient Notification of “Serious Adverse Events”, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=325-015-0045.

Last Updated

Jun. 8, 2021

Rule 325-015-0045’s source at or​.us